Skip to main content
. 2020 Jun 9;22(6):e16056. doi: 10.2196/16056

Table 2.

Patient characteristics of the intervention group matched with a historical comparison group.

Patient characteristics Intervention (n=15) Matched controls (n=30)
Gender (male), n (%) 11 (73) 22 (73)
ASAa classification, n (%)

Ib 3 (20) 5 (16)

IIc 8 (53) 15 (50)

IIId 4 (26) 10 (33)
Age (years), mean (SD) 62.8 (6.9) 60.3 (7)
BMIe, mean (SD) 26.1 (3.5) 25.2 (4)
Comorbidities, n (%)

Cardiovascular 6 (40) 5 (16)

COPDf 0 (0) 3 (10)

DM IIg 1 (7) 1 (3)

Cigarette smoking 1 (7) 7 (23)
Pulmonary function (percent predicted), mean (SD)

FVCh 115.0 (20.1) 116.3 (16.2)

FEV1i 105.4 (20.1) 110.2 (20.7)

IVCj 114.1 (21.9) 112.0 (16.7)
Surgical procedure, n (%)

Transhiatal open 0 (0) 0 (0)

Transhiatal minimally invasive 0 (0) 2 (7)

Transthoracal open 0 (0) 1 (3)

Transthoracal minimally invasive 14 (93) 27 (90)

Esophageal resection with colon interposition 1 (7) 0 (0)
Clavien-Dindo postoperative complications, n (%)

No complications 2 (13) 11 (37)

Grade 1 2 (13) 4 (13)

Grade 2 2 (13) 7 (23)

Grade 3a 3 (20) 4 (13)

Grade 3b 2 (13) 1 (3)

Grade 4a 4 (27) 2 (7)

Grade 4b 0 (0) 1 (3)

Grade 5 0 (0) 0 (0)

aASA: American Society of Anesthesiologists.

bI: healthy person.

cII: mild systemic disease.

dIII: severe systemic disease.

eBMI: body mass index is calculated as weight in kilograms divided by height in meters squared.

fCOPD: chronic obstructive pulmonary disease.

gDM II: diabetes mellitus type 2.

hFVC: functional vital capacity.

iFEV1: forced expiratory volume in the first second of expiration.

jIVC: inspiratory vital capacity.